• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.78% Nasdaq Down 1.13%

    Coherus Biosciences, Inc. (CHRS)

    -NasdaqGM
    19.11 Down 0.86(4.31%) 4:00PM EDT
    |After Hours : 19.11 0.00 (0.00%) 4:00PM EDT
    Prev Close:19.97
    Open:19.68
    Bid:14.14 x 100
    Ask:N/A
    1y Target Est:37.75
    Beta:1.71
    Next Earnings Date: 9-May-16CHRS Earnings announcement
    Day's Range:18.96 - 19.80
    52wk Range:12.04 - 38.10
    Volume:151,187
    Avg Vol (3m):228,945
    Market Cap:747.95M
    P/E (ttm):N/A
    EPS (ttm):-6.01
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CHRS

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):25.88
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-5.84
    Quarterly EPS Est (Mar-16) :-1.42
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Coherus Biosciences, Inc., a late-stage clinical biologics platform company, focuses on developing and commercializing biosimilar products worldwide. The company’s product candidates include CHS-1701, a pegfilgrastim biosimilar candidate, whi... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback